Chocolate in Health and Nutrition pp 409-419

Part of the Nutrition and Health book series (NH, volume 7)

| Cite as

Chocolate: Mood


Key Points

  • Chocolate and mood are strongly intertwined in the popular imagination. The strong body of chocolate lore is not matched by a strong body of evidence.

  • Theoretically, chocolate bears many substances and properties that could influence mood, favorably and adversely. The balance of favorable to adverse effects could differ by individual and timing after chocolate consumption.

  • Favorable effects on mood might be mediated by methylxanthines (caffeine and theobromine), catechins, biogenic amines like serotonin and ethylamine, and cannabinoid receptor agonists like anandamine. Antioxidant functions and cell energy support through mitochondrial biogenesis (mediated by epicatechin) might support positive mood.

  • Detrimental effects on mood might be mediated by methylxanthine excess or withdrawal, effects of copper, or effects of trans-fatty acids (where these have polluted the chocolate product).

  • Empirically, few studies in humans have examined the relation of chocolate to mood. Based on the scant extant literature, mood associations appear to be favorable immediately after eating chocolate that is perceived as palatable. In studies not focused upon the immediate effect, greater chocolate consumption has been linked to lower mood, but it is not clear which (if either) drives which.


Chocolate Mood Depression Methylxanthines Biogenic amines Anandamine Catechins Antioxidant Mmm 


  1. 1.
    Macht M, Dettmer D. Everyday mood and emotions after eating a chocolate bar or an apple. Appetite. 2006;46:332–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Macht M, Mueller J. Immediate effects of chocolate on experimentally induced mood states. Appetite. 2007;49:667–74.PubMedCrossRefGoogle Scholar
  3. 3.
    Barkeling B, Linne Y, Lindroos AK, Birkhed D, Rooth P, Rossner S. Intake of sweet foods and counts of cariogenic microorganisms in relation to body mass index and psychometric variables in women. Int J Obes Relat Metab Disord. 2002;26:1239–44.PubMedCrossRefGoogle Scholar
  4. 4.
    Rose N, Koperski S, Golomb BA. Mood food: chocolate and depressive symptoms in a cross-sectional analysis. Arch Intern Med. 2010;170:699–703.PubMedCrossRefGoogle Scholar
  5. 5.
    Carrieri MP, Cohen J, Winnock M, Salmon D. Chocolate intake, depression, and clinical progression in HIV-HCV coinfected patients: still more questions than answers. Arch Intern Med. 2010;170:1607, author reply 8–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Golomb BA, Koperski S, Rose N. Chocolate consumption and effects on serotonin synthesis – reply. Arch Intern Med. 2010;170:1608–9.CrossRefGoogle Scholar
  7. 7.
    Gardner A, Boles RG. Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression. Biopsychosoc Med. 2008;2:7.PubMedCrossRefGoogle Scholar
  8. 8.
    Golomb BA, Koperski S, White HL. Chocolate consumption is linked to aggression. Circulation. 2011;173(Suppl):P53.Google Scholar
  9. 9.
    Smigrodzki RM, Khan SM. Mitochondrial microheteroplasmy and a theory of aging and age-related disease. Rejuvenation Res. 2005;8:172–98.PubMedCrossRefGoogle Scholar
  10. 10.
    Kujoth GC, Hiona A, Pugh TD, Someya S, Panzer K, Wohlgemuth SE, et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science. 2005;309:481–4.PubMedCrossRefGoogle Scholar
  11. 11.
    Herman JS, Easterbrook PJ. The metabolic toxicities of antiretroviral therapy. Int J STD AIDS. 2001;12:555–62, quiz 63–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Sanchez-Villegas A, Verberne L, De Irala J, Ruíz-Canela M, Toledo E, Serra-Majem L, et al. Dietary fat intake and the risk of depression: the SUN Project. PLoS One. 2011;6:e16268.PubMedCrossRefGoogle Scholar
  13. 13.
    Golomb BA, Evans MA, Dimsdale JE. Trans fat consumption linked to aggression. Circulation. 2008;117:e237.Google Scholar
  14. 14.
    Dos Santos WN, da Silva EG, Fernandes MS, Araujo RG, Costa AC, Vale MG, et al. Determination of copper in powdered chocolate samples by slurry-sampling flame atomic-absorption spectrometry. Anal Bioanal Chem. 2005;382:1099–102.PubMedCrossRefGoogle Scholar
  15. 15.
    Narang RL, Gupta KR, Narang AP, Singh R. Levels of copper and zinc in depression. Indian J Physiol Pharmacol. 1991;35:272–4.PubMedGoogle Scholar
  16. 16.
    Manser WW, Khan MA, Hasan KZ. Trace element studies on Karachi population. Part IV: blood copper, zinc, magnesium and lead levels in psychiatric patients with depression, mental retardation and seizure disorders. J Pak Med Assoc. 1989;39:269–74.PubMedGoogle Scholar
  17. 17.
    Crayton JW, Walsh WJ. Elevated serum copper levels in women with a history of post-partum depression. J Trace Elem Med Biol. 2007;21:17–21.PubMedCrossRefGoogle Scholar
  18. 18.
    Schlegel-Zawadzka M, Zieba A, Dudek D, Zak-Knapik J, Nowak G. Is serum copper a “trait marker” of unipolar depression? A preliminary clinical study. Pol J Pharmacol. 1999;51:535–8.PubMedGoogle Scholar
  19. 19.
    Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep. 2003;8:365–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord. 2001;64:43–51.PubMedCrossRefGoogle Scholar
  21. 21.
    Miller KB, Stuart DA, Smith NL, Lee CY, McHale NL, Flanagan JA, et al. Antioxidant activity and polyphenol and procyanidin contents of selected commercially available cocoa-containing and chocolate products in the United States. J Agric Food Chem. 2006;54:4062–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Vinson JA, Proch J, Bose P, Muchler S, Taffera P, Shuta D, et al. Chocolate is a powerful ex vivo and in vivo antioxidant, an antiatherosclerotic agent in an animal model, and a significant contributor to antioxidants in the European and American Diets. J Agric Food Chem. 2006;54:8071–6.PubMedCrossRefGoogle Scholar
  23. 23.
    Gu L, House SE, Wu X, Ou B, Prior RL. Procyanidin and catechin contents and antioxidant capacity of cocoa and chocolate products. J Agric Food Chem. 2006;54:4057–61.PubMedCrossRefGoogle Scholar
  24. 24.
    Serafini M, Bugianesi R, Maiani G, Valtuena S, De Santis S, Crozier A. Plasma antioxidants from chocolate. Nature. 2003;424:1013.PubMedCrossRefGoogle Scholar
  25. 25.
    Spadafranca A, Martinez Conesa C, Sirini S, Testolin G. Effect of dark chocolate on plasma epicatechin levels, DNA resistance to oxidative stress and total antioxidant activity in healthy subjects. Br J Nutr. 2010;103:1008–14.PubMedCrossRefGoogle Scholar
  26. 26.
    Lehner C, Gehwolf R, Tempfer H, Krizbai I, Hennig B, Bauer HC, et al. Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases. Antioxid Redox Signal. 2011;15:1305–23.PubMedCrossRefGoogle Scholar
  27. 27.
    Barichello T, Lemos JC, Generoso JS, Cipriano AL, Milioli GL, Marcelino DM, et al. Oxidative stress, cytokine/chemokine and disruption of blood-brain barrier in neonate rats after meningitis by Streptococcus agalactiae. Neurochem Res. 2011;36(10):1922–30.PubMedCrossRefGoogle Scholar
  28. 28.
    Lukic-Panin V, Deguchi K, Yamashita T, Shang J, Zhang X, Tian F, et al. Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage. Curr Neurovasc Res. 2010;7:319–29.PubMedCrossRefGoogle Scholar
  29. 29.
    Lochhead JJ, McCaffrey G, Quigley CE, Lochhead JJ, McCaffrey G, Quigley CE, et al. Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab. 2010;30:1625–36.PubMedCrossRefGoogle Scholar
  30. 30.
    Eteng MU, Eyong EU, Akpanyung EO, Agiang MA, Aremu CY. Recent advances in caffeine and theobromine toxicities: a review. Plant Foods Hum Nutr. 1997;51:231–43.PubMedCrossRefGoogle Scholar
  31. 31.
    Pastore P, Favaro G, Badocco D, Tapparo A, Cavalli S, Saccani G. Determination of biogenic amines in chocolate by ion chromatographic separation and pulsed integrated amperometric detection with implemented wave-form at Au disposable electrode. J Chromatogr A. 2005;1098:111–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Bruinsma K, Taren DL. Chocolate: food or drug? J Am Diet Assoc. 1999;99:1249–56.PubMedCrossRefGoogle Scholar
  33. 33.
    Yamada T, Yamada Y, Okano Y, Terashima T, Yokogoshi H. Anxiolytic effects of short- and long-term administration of cacao mass on rat elevated T-maze test. J Nutr Biochem. 2009;20:948–55.PubMedCrossRefGoogle Scholar
  34. 34.
    Broadley KJ, Akhtar Anwar M, Herbert AA, Fehler M, Jones EM, Davies WE, et al. Effects of dietary amines on the gut and its vasculature. Br J Nutr. 2009;101:1645–52.PubMedCrossRefGoogle Scholar
  35. 35.
    Smit HJ. Theobromine and the pharmacology of cocoa. Handb Exp Pharmacol. 2011;200:201–34.PubMedCrossRefGoogle Scholar
  36. 36.
    Hadfield MG. Caffeine and the olfactory bulb. Mol Neurobiol. 1997;15:31–9.PubMedCrossRefGoogle Scholar
  37. 37.
    Richardson NJ, Rogers PJ, Elliman NA, O’Dell RJ. Mood and performance effects of caffeine in relation to acute and chronic caffeine deprivation. Pharmacol Biochem Behav. 1995;52:313–20.PubMedCrossRefGoogle Scholar
  38. 38.
    Smith A. Effects of caffeine on human behavior. Food Chem Toxicol. 2002;40:1243–55.PubMedCrossRefGoogle Scholar
  39. 39.
    Ozsungur S, Brenner D, El-Sohemy A. Fourteen well-described caffeine withdrawal symptoms factor into three clusters. Psychopharmacology (Berl). 2009;201:541–8.CrossRefGoogle Scholar
  40. 40.
    Ratliff-Crain J, O’Keeffe MK, Baum A. Cardiovascular reactivity, mood, and task performance in deprived and nondeprived coffee drinkers. Health Psychol. 1989;8:427–47.PubMedCrossRefGoogle Scholar
  41. 41.
    Lane JD, Phillips-Bute BG. Caffeine deprivation affects vigilance performance and mood. Physiol Behav. 1998;65:171–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Phillips-Bute BG, Lane JD. Caffeine withdrawal symptoms following brief caffeine deprivation. Physiol Behav. 1997;63:35–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Herraiz T. Tetrahydro-beta-carbolines, potential neuroactive alkaloids, in chocolate and cocoa. J Agric Food Chem. 2000;48:4900–4.PubMedCrossRefGoogle Scholar
  44. 44.
    Villareal F. Chocolate: an exercise mimetic? In: Southwest chapter American College of Sports Medicine 2010 annual meeting, San Diego: American College of Sports Medicine; 2010.Google Scholar
  45. 45.
    Blumenthal J, Babyak M, Moore K, Craighead WE, Herman S, Khatri P, et al. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159:2349–56.PubMedCrossRefGoogle Scholar
  46. 46.
    Craft LL, Landers DM. The effect of exercise on clinical depression and depression resulting from mental illness: a meta-analysis. J Sport Exerc Psychol. 1998;20:339–57.Google Scholar
  47. 47.
    Larque E, Perez-Llamas F, Puerta V, Girón MD, Suárez MD, Zamora S, et al. Dietary trans fatty acids affect docosahexaenoic acid concentrations in plasma and liver but not brain of pregnant and fetal rats. Pediatr Res. 2000;47:278–83.PubMedCrossRefGoogle Scholar
  48. 48.
    Hibbeln JR, Ferguson TA, Blasbalg TL. Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: opportunities for intervention. Int Rev Psychiatry. 2006;18:107–18.PubMedCrossRefGoogle Scholar
  49. 49.
    Hibbeln JR, Lewis M, Johnson J, Lin YH, Umhau JC. Low omega-3 fatty acid status and increased risk of suicide death among active duty US military: A case control comparison. ISSFAL International Congress Maastricht Netherlands; June 2010.Google Scholar
  50. 50.
    Hibbeln JR, Salem Jr N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr. 1995;62:1–9.PubMedGoogle Scholar
  51. 51.
    Kurata N, Privett OS. Effects of dietary trans acids on the biosynthesis of arachidonic acid in rat liver microsomes. Lipids. 1980;15:1029–36.PubMedCrossRefGoogle Scholar
  52. 52.
    Vorona RD, Ware JC. Exacerbation of REM sleep behavior disorder by chocolate ingestion: a case report. Sleep Med. 2002;3:365–7.PubMedCrossRefGoogle Scholar
  53. 53.
    Okudaira N, Kripke DF, Mullaney DJ. Theophylline delays human sleep phase. Life Sci. 1984;34:933–8.PubMedCrossRefGoogle Scholar
  54. 54.
    Flemons WW, Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol. 1997;99:S750–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Guilleminault C, Lin CM, Goncalves MA, Ramos E. A prospective study of nocturia and the quality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia. J Psychosom Res. 2004;56:511–5.PubMedCrossRefGoogle Scholar
  56. 56.
    di Tomaso E, Beltramo M, Piomelli D. Brain cannabinoids in chocolate. Nature. 1996;382:677–8.PubMedCrossRefGoogle Scholar
  57. 57.
    James JS. Marijuana and chocolate. AIDS Treat News. 1996;257:3–4.Google Scholar
  58. 58.
    Maccioni P, Pes D, Carai MA, Gessa GL, Colombo G. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats. Behav Pharmacol. 2008;19:197–209.PubMedCrossRefGoogle Scholar
  59. 59.
    Kuiper-Goodman T. Mycotoxins: risk assessment and legislation. Toxicol Lett. 1995;82–83:853–9.PubMedCrossRefGoogle Scholar
  60. 60.
    Warzecha A, Jakubowska B, Siwicka H. Microflora of cocoa pulp and its effect on contamination of ready-made confectionery. Rocz Panstw Zakl Hig. 1985;36:154–63.PubMedGoogle Scholar
  61. 61.
    Joo S-J, Betts NM. Copper intakes and consumption patterns of chocolate foods as sources of copper for individuals in the 1987–1988 Nationwide Food Consumption Survey. Nutr Res. 1996;16:41–52.CrossRefGoogle Scholar
  62. 62.
    Wood JE, Allaway D, Boult E, Scott IM. Operationally realistic validation for prediction of cocoa sensory qualities by high-throughput mass spectrometry. Anal Chem. 2010;82:6048–55.PubMedCrossRefGoogle Scholar
  63. 63.
    Wolz M, Kaminsky A, Lohle M, Koch R, Storch A, Reichmann H. Chocolate consumption is increased in Parkinson’s disease. Results from a self-questionnaire study. J Neurol. 2009;256:488–92.PubMedCrossRefGoogle Scholar
  64. 64.
    Strandberg TE, Strandberg AY, Pitkala K, Salomaa VV, Tilvis RS, Miettinen TA. Chocolate, well-being and health among elderly men. Eur J Clin Nutr. 2008;62:247–53.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2013

Authors and Affiliations

  1. 1.Department of Internal Medicine, San Diego School of MedicineUniversity of CaliforniaSan DiegoUSA
  2. 2.Department of Medicine and Department of Family and Preventive Medicine, San Diego School of MedicineUniversity of CaliforniaLa JollaUSA

Personalised recommendations